Annals of Tropical Medicine and Parasitology

A decade of ivermectin-albendazole donation for lymphatic filariasis
pp. 3-3(1)
Authors: Hopkins, A.D.; Molyneux, D.H.

Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis
pp. 5-10(6)
Author: Brantus, P.

GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis
pp. 11-15(5)
Authors: Gustavsen, K.M.; Bradley, M.H.; Wright, A.L.

The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007)
pp. 17-21(5)
Authors: Hooper, P.J.; Bradley, M.H.; Biswas, G.; Ottesen, E.A.

Challenges for the integration of mass drug administrations against multiple 'neglected tropical diseases'
pp. 23-31(9)
Author: Hopkins, A.D.

The development of albendazole for lymphatic filariasis
pp. 33-40(8)
Author: Horton, J.

Lymphatic filariasis: patients and the global elimination programme
pp. 41-51(11)
Authors: Mackenzie, C.D.; Lazarus, W.M.; Mwakitalu, M.E.; Mwingira, U.; Malecela, M.N.

The sharp end — experiences from the Tanzanian programme for the elimination of lymphatic filariasis: notes from the end of the road
pp. 53-57(5)
Authors: Malecela, M.N.; Mwingira, U.; Mwakitalu, M.E.; Kabali, C.; Michael, E.; Mackenzie, C.D.